Merck KGaA - Pfizer Alliance
Alliance between Merck KGaA, Darmstadt, Germany, and Pfizer Inc., New York, US
The global strategic alliance is focused on developing high-priority international clinical programs to investigate avelumab as a monotherapy, as well as in combination regimens, and is striving to find new ways to treat cancer.